Plain-English translation of NCT07353502 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Alzheimer Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are looking for special biological markers in your blood and cerebrospinal fluid (the fluid around your brain and spinal cord) that might signal early Alzheimer's disease. By comparing samples from people with Alzheimer's to healthy volunteers, they hope to identify patterns that could help doctors catch the disease earlier, before major memory problems develop.
Right now, doctors often diagnose Alzheimer's disease only after serious memory loss has already happened. This study exists to find early warning signs in the blood and spinal fluid that could allow detection and treatment much earlier, potentially when interventions might be more helpful.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have blood drawn and may be asked to undergo a lumbar puncture to collect cerebrospinal fluid from around your spine. These samples will be tested for special biological markers related to early Alzheimer's disease. The study involves 40 participants total — some with Alzheimer's disease and some healthy controls — and samples are collected at one or more clinic visits.
AI-generated summary from trial data · Jun 25, 2026 · Not medical advice
China